CONFIDENCE in the safety and efficacy of dual therapy with an SGLT ‐2 inhibitor and finerenone in patients with chronic kidney disease and type 2 diabetes
Year: 2025
Type: article
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.70026
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $5,380
OpenAlex ID: W4413100533
